| Literature DB >> 29724870 |
Ana Catarina Teixeira1, Helena Pinto2, Nuno Oliveira2, Carol Marinho3.
Abstract
The antiglomerular basement membrane (anti-GBM) antibody disease is marked by the presence of specific antibodies against the non-collagenous domain of the type IV collagen's α3 chain. We describe a case of a 24-year-old Caucasian man, who may have had an atypical presentation of anti-GBM (slow progressive renal insufficiency, massive proteinuria and no detectable circulating anti-GBM antibody). The patient was treated with steroids and cyclophosphamide. This approach failed to attenuate the disease, and so rituximab was initiated with subsequent clinical improvement, normalisation of urinary sediment and marked regression of proteinuria; renal function remained stable. The renal biopsy immunofluorescence was crucial for the diagnosis. © BMJ Publishing Group Ltd (unless otherwise stated in the text of the article) 2018. All rights reserved. No commercial use is permitted unless otherwise expressly granted.Entities:
Keywords: acute renal failure; nephrotic syndrome
Mesh:
Substances:
Year: 2018 PMID: 29724870 PMCID: PMC5935154 DOI: 10.1136/bcr-2017-223198
Source DB: PubMed Journal: BMJ Case Rep ISSN: 1757-790X